| [1] | Council Regulation 1/2003 of 16 December 2002 on the Implementation of the Rules on Competition Laid Down in Articles 81 and 82 of the Treaty; European Commission: Brussels, Belgium, 2003; p. 61.
|
| [2] | Goyder, DG. EC Competition Law; Oxford University Press: Oxford, UK, 2003; p. 664.
|
| [3] | Fornaciari, D; Callens, S; Devroe, W. Mededinging in de gezondheidszorg. Gezondheidsrechtelijke aspecten. NJW？2009, 195, 50–62.
|
| [4] | Hyman, D. Improving Healthcare A dose of competition; Springer: Dordrecht, The Netherlands, 2005; p. 430.
|
| [5] | Maasdam, YA; van de Meent, GWA. Wet Marktordening Gezondheidszorg; SdU Uitgevers: Den Haag, The Netherlands, 2007; p. 285.
|
| [6] | Sage, WM; Hyman, DA; Greenberg, W. Why competition law matters to health care quality. Health Affair？2003, 22, 31–44.
|
| [7] | Gaynor, M. What do we know about competition and quality in health care markets. NBER Work Pap？2006, (12301).
|
| [8] | Jacobi, JV. Competition Law’s Role in health care quality. Ann. Health L？2002, 11, 45–71.
|
| [9] | Cannon, MF; Tanner, MD. Healthy Competition? What’s Holding Back Health Care and How to Free It; Cato Institute: Washington, D.C., USA, 2007; p. 366.
|
| [10] | Kessler, D; McClellan, M. Is hospital competition socially wasteful? Quart. J. Econ？2000, 115, 577–615.
|
| [11] | Tay, A. Assessing competition in hospital care markets: the importance of accounting for quality differentiation. RAND J. Econ？2003, 34, 786–814.
|
| [12] | Gowrisankaran, G; Town, R. Competition, payers and hospital quality. Health Serv. Rese？2003, 38, 1403–1422.
|
| [13] | Sage, WM; Hammer, PJ. Competing on quality of care; the need to develop a competition policy for healthcare markets. U. Mich. J.L. Ref.？1999.
|
| [14] | Donabedian, A. The Definition of Quality and Approaches to Its Assessment; MI Health Administration Press: Ann Arbor, MI, USA, 1980; p. 176.
|
| [15] | Wong, HS; McNamara, P. Provider competition and health care quality: challenges and opportunities for research. Int. J. Health Care Finance Econ？2004, 4, 99–111.
|
| [16] | Hyman, D. Five reasons why health care quality research hasn’t affected competition law and policy. Int. J. Health Care Finance Econ？2004, 4, 159–166.
|
| [17] | Kauper, TE. The role of quality of health care considerations in antitrust analysis. Law Contemp. Probs？1988, 51, 273–340.
|
| [18] | Guidelines on the Applicability of Article 81 (3) of the Treaty; European Commission: Brussels, Belgium, 2004; p. 101.
|
| [19] | Guidelines on the Assessment of Horizontal Mergers under the Council Regulation on the Control of Concentrations between Undertakings; European Commission: Brussels, Belgium, 2004; p. 31.
|
| [20] | Janssen, MCW; Schep, K; Van Sinderen, J. Fusies van ziekenhuizen. Het beoordelingskader van de NMa. Markt. Mededinging？2009, 2, 44–53.
|
| [21] | Communication of the Commission. White Paper on Services of General Interest, 2004, p. 375.
|
| [22] | Community framework for State Aid in the Form of Public Service Compensation; European Commission: Brussels, Belgium, 2005; p. 297.
|
| [23] | Decision of the Commission N 542/2004 Introduction of a Risk Equalization System in the Dutch Health Insurance; European Commission: Brussels, Belgium, 2006; p. 108.
|
